Noberastine

TargetMol
Product Code: TAR-T25875
Supplier: TargetMol
CodeSizePrice
TAR-T25875-1mg1mg£188.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25875-5mg5mg£352.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25875-10mg10mg£496.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25875-25mg25mg£894.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25875-50mg50mg£1,195.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25875-100mg100mg£1,805.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Noberastine is a H1-receptor antagonist.
CAS:
110588-56-2
Formula:
C17H21N5O
Molecular Weight:
311.389
Pathway:
Immunology/Inflammation|Neuroscience|GPCR/G Protein
Purity:
0.98
SMILES:
Cc1ccc(Cn2c(NC3CCNCC3)nc3cccnc23)o1
Target:
Histamine Receptor

References

1. Wood-Baker R, Emanuel MB, Hutchinson K, Howarth PH. The time course of action of three differing doses of noberastine, a novel H1-receptor antagonist, on histamine-induced skin wheals and the relationship to plasma drug concentrations in normal human volunteers. Br J Clin Pharmacol. 1993 Feb;35(2):166-70. PubMed PMID: 8095149; PubMed Central PMCID: PMC1381509. 2. Kamali F, Emanuel M, Rawlins MD. A double-blind placebo controlled dose response study of noberastine on histamine induced weal and flare. Eur J Clin Pharmacol. 1991;40(1):83-5. PubMed PMID: 1676366. 3. Knight A, Drouin MA, Yang WH, Alexander M, Del Carpio J, Arnott WS. Clinical evaluation of the efficacy and safety of noberastine, a new H1 antagonist, in seasonal allergic rhinitis: a placebo-controlled, dose-response study. J Allergy Clin Immunol. 1991 Dec;88(6):926-34. PubMed PMID: 1683882. 4. Lau HY, Tsang CW, Wong PP. Effects of acrivastine, azelastine, cetirizine and noberastine on rat peritoneal mast cells. Inflamm Res. 1995 Apr;44 Suppl 1:S30-1. PubMed PMID: 8520987.